Cargando…
The 95% effective dose of nalbuphine in patient-controlled intravenous analgesia for patients undergoing laparoscopic total hysterectomy compared to equivalent sufentanil: Retraction
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276379/ https://www.ncbi.nlm.nih.gov/pubmed/35713449 http://dx.doi.org/10.1097/MD.0000000000029420 |
Ejemplares similares
-
The 95% effective dose of nalbuphine in patient-controlled intravenous analgesia for patients undergoing laparoscopic total hysterectomy compared to equivalent sufentanil: Retraction
por: Sun, Zhentao, et al.
Publicado: (2020) -
Analgesic Effect Comparison Between Nalbuphine and Sufentanil for Patient-Controlled Intravenous Analgesia After Cesarean Section
por: Sun, Shen, et al.
Publicado: (2020) -
Sufentanil Combined with Nalbuphine via Patient-Controlled Intravenous Analgesia After Cesarean Section: A Retrospective Evaluation
por: Wang, Lini, et al.
Publicado: (2022) -
Retracted: The Influence of Different Dexmedetomidine Doses on Cognitive Function at Early Period of Patients Undergoing Laparoscopic Extensive Total Hysterectomy
por: Healthcare Engineering, Journal of
Publicado: (2022) -
Analgesic Effects and Safety of Dexmedetomidine Added to Nalbuphine or Sufentanil Patient-Controlled Intravenous Analgesia for Children After Tonsillectomy Adenoidectomy
por: Jia, Yingping, et al.
Publicado: (2022)